(1)
Purnamayanti, A.; Suharjono, S.; Rahmadi, M. Optimization of ADMET Properties Prediction for Remdesivir, Favipiravir, and Their Metabolites Elimination Profiles. Borneo J Pharm 2026, 9 (1), 71-76. https://doi.org/10.33084/bjop.v9i1.8464.